Table 2.

Evolution of BCVA and CMT during the follow-up period.

Parameter	BCVA (IQR), logMAR	P -value	CMT (IQR), $\mu$ m	P -value
Baseline	0.6 (0.4–1.0)	–	490.0 (394.5–668.0)	–
6 months	0.4 (0.2–0.7)	$<$ 0.01	326.5 (280.3–433.0)	$<$ 0.01
12 months	0.4 (0.2–0.7)	$<$ 0.01	325.0 (278.0–414.0)	$<$ 0.01
Median (IQR). Differences were evaluated versus the initial visit BCVA, best corrected visual acuity; CMT, central macular thickness; IQR, interquartile range